Three companies owned businesses that got stronger during the pandemic, and also have the potential to outperform with the advent of a vaccine.
Tales of a few temples remembered for odd offerings to the presiding deities are among India's most fascinating stories.
It is likely to be powered by Snapdragon 662 chipset and offers 4 GB RAM and up to 128 GB of internal storage.
WisdomTree Issuer plc – Daily Fund Prices 26-January-21 WisdomTree Artificial Intelligence UCITS ETF - USD Acc26/01/2021IE00BDVPNG135588541USD379,633,595.3267.9307WisdomTree AT1 CoCo Bond UCITS ETF – USD26/01/2021IE00BZ0XVF52513029USD53,159,591.09103.6191WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged26/01/2021IE00BFNNN236279036EUR28,719,682.73102.9247WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged26/01/2021IE00BFNNN45934640GBP3,611,711.36104.2642WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc26/01/2021IE00BZ0XVG6942463USD5,102,559.29120.1648WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged26/01/2021IE00BFNNN01217006USD1,861,618.86109.4684WisdomTree Battery Solutions UCITS ETF - USD Acc26/01/2021IE00BKLF1R755933534USD293,874,523.6549.5277WisdomTree Cloud Computing UCITS ETF - USD Acc26/01/2021IE00BJGWQN7211494000USD613,613,545.3153.3856WisdomTree Cybersecurity UCITS ETF - USD Acc26/01/2021IE00BLPK357740000USD973,712.3124.3428WisdomTree Emerging Markets Equity Income UCITS ETF26/01/2021IE00BQQ3Q0672583191USD38,610,200.6814.9467WisdomTree Emerging Markets Equity Income UCITS ETF Acc26/01/2021IE00BDF12W49190558USD4,049,119.2321.2487WisdomTree Emerging Markets Small Cap Dividend UCITS ETF26/01/2021IE00BQZJBM261630000USD29,930,869.7518.3625WisdomTree Enhanced Commodity UCITS ETF – CHF Hedged Acc26/01/2021IE00BG88WL21185000CHF1,929,107.8610.4276WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc26/01/2021IE00BG88WG771750000EUR17,035,938.579.7348WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc26/01/2021IE00BG88WH841200000GBP11,900,692.719.9172WisdomTree Enhanced Commodity UCITS ETF - USD26/01/2021IE00BZ1GHD37600000USD6,323,479.9910.5391WisdomTree Enhanced Commodity UCITS ETF - USD Acc26/01/2021IE00BYMLZY748050000USD88,317,348.3510.9711WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR26/01/2021IE00BD49R912210439EUR11,666,376.6055.4383WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc26/01/2021IE00BD49RB3959498EUR3,375,314.1156.7299WisdomTree EUR Government Bond Enhanced Yield UCITS ETF26/01/2021IE00BD49RJ1519908EUR1,127,702.9656.6457WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc26/01/2021IE00BD49RK2040000EUR2,319,028.7257.9757WisdomTree Europe Equity Income UCITS ETF26/01/2021IE00BQZJBX311732717EUR18,603,660.2110.7367WisdomTree Europe Equity Income UCITS ETF Acc26/01/2021IE00BDF16007352386EUR4,790,767.8913.5952WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc26/01/2021IE00BYQCZT117703CHF137,778.2817.8863WisdomTree Europe Equity UCITS ETF - EUR Acc26/01/2021IE00BYQCZX56269545EUR4,915,286.3918.2355WisdomTree Europe Equity UCITS ETF - GBP Hedged26/01/2021IE00BYQCZQ89131454GBP1,501,005.7511.4185WisdomTree Europe Equity UCITS ETF - USD Hedged26/01/2021IE00BVXBH1631135423USD21,544,759.9518.9751WisdomTree Europe Equity UCITS ETF - USD Hedged Acc26/01/2021IE00BYQCZP722018673USD45,169,456.2822.3758WisdomTree Europe Small Cap Dividend UCITS ETF26/01/2021IE00BQZJC5271595372EUR27,380,187.5617.1623WisdomTree Europe Small Cap Dividend UCITS ETF Acc26/01/2021IE00BDF16114277191EUR4,405,290.2915.8926WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR26/01/2021IE00BZ56SY76630208EUR11,203,628.7117.7777WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc26/01/2021IE00BZ56TQ67679042EUR13,813,920.7420.3432WisdomTree Global Quality Dividend Growth UCITS ETF - USD26/01/2021IE00BZ56RN96308660USD8,710,076.0628.219WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc26/01/2021IE00BZ56SW521750284USD53,645,148.6530.6494WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc26/01/2021IE00BYQCZL35235650CHF4,600,896.1519.5243WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc26/01/2021IE00BYQCZJ13201551EUR3,368,311.8916.712WisdomTree Japan Equity UCITS ETF - GBP Hedged26/01/2021IE00BYQCZF7489539GBP960,919.4910.7319WisdomTree Japan Equity UCITS ETF - JPY Acc26/01/2021IE00BYQCZN58189960USD4,231,876.2722.2777WisdomTree Japan Equity UCITS ETF - USD Hedged26/01/2021IE00BVXC48541451738USD24,649,765.7716.9795WisdomTree Japan Equity UCITS ETF - USD Hedged Acc26/01/2021IE00BYQCZD50400818USD7,809,431.0619.4837WisdomTree UK Equity Income UCITS ETF26/01/2021IE00BYPGTJ261800000GBP7,648,503.584.2492WisdomTree US Equity Income UCITS ETF26/01/2021IE00BQZJBQ63804894USD15,439,114.0119.1815WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc26/01/2021IE00BD6RZW238073EUR136,352.3516.8899WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc26/01/2021IE00BD6RZZ53379189GBP5,752,846.3115.1714WisdomTree US Equity Income UCITS ETF Acc26/01/2021IE00BD6RZT931455101USD29,778,537.3720.4649WisdomTree US Quality Dividend Growth UCITS ETF - USD26/01/2021IE00BZ56RD98436031USD12,256,905.5128.1102WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc26/01/2021IE00BZ56RG202012843USD60,991,316.0230.3011WisdomTree USD Floating Rate Treasury Bond UCITS ETF - USD26/01/2021IE00BJFN5P6320916USD1,049,078.6350.1568WisdomTree USD Floating Rate Treasury Bond UCITS ETF - USD Acc26/01/2021IE00BJJYYX67358822USD18,300,789.1451.0024
Alter Domus ("Alter Domus" or the "Company"), a leading provider of integrated solutions for the alternative investment industry, announces the creation of 100 new jobs, substantially increasing headcount at its European Centre of Excellence in Cork.
The "Drug Eluting Balloons (DEBs) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
BRUSSELS — AstraZeneca has pulled out of meeting with the European Union to discuss delayed vaccine commitments to the bloc, an EU official said. The official, who asked not to be identified because of the sensitivity of the talks, said the EU would “insist on them” coming back to the negotiating table to explain the delay in deliveries once the Oxford-AstraZeneca vaccine gets approved for use by the European Medicines Agency. The EU's drug regulator was scheduled to hold on meeting on approving the vaccine on Friday. Wednesday’s talks with the EU Commission and member states were slated to be the third in as many days, as an ever angrier EU is demanding an explanation about the delays. AstraZeneca said in a statement that they “understand and share in the frustration that initial supply volumes of our vaccine delivered to the European Union will be lower than forecast." It did not address the issue of the planned meeting with the EU's steering board, which brings together experts from the executive Commission, the member states, and in this case, hopefully AstraZeneca. On Monday, the EU threatened to impose tight export controls within days on COVID-19 vaccines made in the bloc. The EU, which has 450 million citizens and the economic and political clout of the world's biggest trading bloc, is lagging badly behind countries like Israel and Britain in rolling out coronavirus vaccine shots for its health care workers and most vulnerable people. That's despite having over 400,000 confirmed virus deaths since the pandemic began. The shortfall of planned deliveries of the AstraZeneca vaccine combined with hiccups in the distribution of Pfizer-BioNTech shots as that company upgrades production facilities at a plant in Belgium is putting EU nations under heavy political pressure. ___ Follow all of AP’s pandemic coverage at: https://apnews.com/hub/coronavirus-pandemic https://apnews.com/hub/coronavirus-vaccine https://apnews.com/UnderstandingtheOutbreak Raf Casert, The Associated Press
The England head coach says the prop will be considered for future selection when available again.
Future-Ready organizations leveraging digital to operate faster and smarter could help unlock $5 trillion in economic growth, says Accenture.
Dublin, Jan. 27, 2021 (GLOBE NEWSWIRE) -- The "Saudi Arabia Elevator & Escalator Market by Type (Elevator, Escalator and Moving Walkways), by Service (Maintenance & Repair, New Installation and Modernization), by Elevator Technology, by End-User, by Elevator Door Type, by Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Saudi Arabian Elevator & Escalator Market was valued USD 1049.87 Million in 2019 and is forecast to grow at CAGR of 6.86% in value terms, to reach USD 1340.09 Million by 2025. Booming construction sector, increasing number of high-rise building projects and rapid infrastructure development are the key factors driving the Saudi Arabian Elevator & Escalator Market. Under its "Vision 2030" program, Saudi Arabia is trying to diversify its economy from oil to non-oil-based and therefore, working on developing tourism & corporate hubs in the country, which in turn is expected to increase the number of buildings, thereby boosting the demand for elevator and excavator during the forecast period. As the investments for travel & tourism and smart infrastructure are increasing, elevator and excavator market is likely to grow in the coming years in Saudi Arabia.The Saudi Arabian Elevator & Escalator Market is segmented based on type, service, elevator technology, end-user, elevator door type, and region. Based on type, the market can be segmented into elevator, escalator and moving walkways. The elevator segment accounted for share of 88.32% in 2019 and is anticipated to continue dominance until 2025 owing to their widespread use in various end-user industries. Based on elevator technology, the market can be fragmented into traction, hydraulic and machine room-less traction. The machine room-less traction segment grabbed the largest market share in 2019 and is also expected to grow at the fastest pace during forecast period on account of their higher efficiency and smoother ride.Regionally, the Saudi Arabian Elevator & Escalator Market has been segmented into Riyadh, Makkah, and Easter Province. Among these regions, Riyadh is expected to dominate the country's elevator & escalator market majorly due booming construction sector in the region.Major players operating in the Saudi Arabian Elevator & Escalator Market include Otis Elevator Company Saudi Arabia Limited, Schindler Olayan Elevators Co. Ltd, ThyssenKrupp Elevator Saudi Limited, Mitsubishi Electric Saudi Ltd., Gulf Elevator & Escalator Company Ltd., Khaled Juffali Elevator & Escalator Co., KONE Saudi Arabia, Orona Elevator Co. KSA, Fujitec Saudi Arabia Co., Ltd., Hyundai Elevator Saudi Arabia, among others.Years considered for this report: Historical Years: 2015 - 2018Base Year: 2019Estimated Year: 2020Forecast Period: 2021 - 2025 Key Topics Covered: 1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Saudi Arabia Elevator & Escalator Market5. Voice of Customer5.1. Brand Awareness5.2. Brand Satisfaction5.3. Factors Influencing Purchase Decision5.4. Annual Maintenance Service6. Saudi Arabia Elevator & Escalator Market Outlook6.1. Market Size & Forecast6.1.1. By Value & Volume6.2. Market Share & Forecast6.2.1. By Type (Elevator, Escalator and Moving Walkways)6.2.2. By Service (Maintenance & Repair, New Installation and Modernization)6.2.3. By Elevator Technology (Traction, Hydraulic and Machine Room-Less Traction)6.2.4. By End-User (Residential, Commercial, Institutional, Infrastructural and Others)6.2.5. By Elevator Door Type (Automatic and Manual)6.2.6. By Region (Riyadh, Makkah, Eastern Province, Rest of Saudi Arabia)6.2.7. By Company6.3. Product Market Mapping6.3.1. By Type (Elevator, Escalator and Moving Walkways)6.3.2. By Service (Maintenance & Repair, New Installation and Modernization)6.3.3. By Elevator Technology (Traction, Hydraulic and Machine Room-Less Traction)6.3.4. By End-User (Residential, Commercial, Institutional, Infrastructural and Others)6.3.5. By Elevator Door Type (Automatic and Manual)7. Saudi Arabia Maintenance & Repair Elevator & Escalator Market Outlook7.1. Market Size & Forecast7.1.1. By Value & Volume7.2. Market Share & Forecast7.2.1. By Type7.2.2. By End-User8. Saudi Arabia New Installation Elevator & Escalator Market Outlook8.1. Market Size & Forecast8.1.1. By Value8.2. Market Share & Forecast8.2.1. By Type8.2.2. By End-User9. Saudi Arabia Modernization Elevator & Escalator Market Outlook9.1. Market Size & Forecast9.1.1. By Value & Volume9.2. Market Share & Forecast9.2.1. By Type9.2.2. By End-User10. Value Chain Analysis11. Market Dynamics11.1. Drivers/Opportunities11.2. Challenges/Restraints12. Market Trends & Developments13. Policy & Regulatory Landscape14. Saudi Arabia Economic Profile15. Competitive Landscape15.1. Otis Elevator Company Saudi Arabia Limited15.2. Schindler Olayan Elevators Co. Ltd15.3. ThyssenKrupp Elevator Saudi Limited15.4. Mitsubishi Electric Saudi Ltd.15.5. Gulf Elevator & Escalator Company Ltd.15.6. Khaled Juffali Elevator & Escalator Co.15.7. KONE Saudi Arabia15.8. Orona Elevator Co. KSA15.9. Fujitec Saudi Arabia Co., Ltd.15.10. Hyundai Elevator Saudi Arabia16. Strategic Recommendations For more information about this report visit https://www.researchandmarkets.com/r/vvsgt0 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The Spaniard is the top points scorer in the competition’s history.
Will my exposure to 'forever chemicals' make the Covid-19 vaccine less effective?There is growing evidence that people with high exposure to PFAS ‘forever chemicals’ are less protected by vaccines ‘By depressing the immune system, PFAS inhibit the development of a strong antibody response.’ Photograph: Anadolu Agency/Getty Images
The Democrats' priority in power must be to stop minority rule. This is no time for incrementalism. Only a bold effort to strengthen US democracy will prevent the return of rightwing minority rule
The cinema chain, which is the second most shorted UK listed company, according to Short Tracker, follows in the footsteps of GameStop.
Tasse's latest promotion follows 25 years of progressive roles with Lee Valley as the company navigates retail realities and newly inspired consumersOTTAWA, ON, Jan. 27, 2021 /CNW/ - Lee Valley Tools, a leading provider of hardware, woodworking, gardening and kitchen tools in Canada since 1977, announced today that Jason Tasse, a 25-year employee with the company, is appointed President and will retain his role as Chief Operating Officer.
Severe delays in property sales could leave many buyers wishing they had not bothered.
WASHINGTON — For nearly a year it was the Trump show. Now President Joe Biden is calling up the nation’s top scientists and public health experts to regularly brief the American public about the pandemic that has claimed more than 425,000 U.S. lives. Beginning Wednesday, administration experts will host briefings three times a week on the state of the outbreak, efforts to control it and the race to deliver vaccines and therapeutics to end it. Expect a sharp contrast from the last administration's briefings, when public health officials were repeatedly undermined by a president who shared his unproven ideas without hesitation. “We’re bringing back the pros to talk about COVID in an unvarnished way,” Biden told reporters Tuesday. “Any questions you have, that’s how we’ll handle them because we’re letting science speak again.” The new briefings, beginning just a week into Biden’s tenure, are meant as an explicit rejection of his predecessor’s approach to the coronavirus outbreak. President Donald Trump claimed centre stage and muddled the message of the nation’s top public health experts in the critical early days of the virus and eventually largely muzzled them as the pandemic's mortal toll grew steeper. The new briefings are part of Biden’s attempt to rebuild public confidence in institutions, particularly the federal government, with a commitment to share the bad news with the good. “I’ll always level with you about the state of affairs,” he said Tuesday, repeating a central pledge of his inaugural address. It’s a message that helped carry Biden to the White House. As a candidate he warned that the nation faced a surge of coronavirus cases in what would be a “dark winter"; Trump, for his part, falsely claimed the worst of the virus was over. Dr. David Hamer, a professor of global health and medicine at Boston University’s School of Public Health, said having briefings from health officials that are “based on serious science” would go a long way toward improving public perceptions of the vaccine. “There’s a certain amount of vaccine hesitancy, and so educating people about the vaccine, how it works, how safe it is and how it can protect against the disease but also slow transmission is really important,” he said. The stakes for Biden, whose presidency hinges on his handling of the pandemic and the largest vaccination campaign in global history, could hardly be higher. Biden is pushing a weary populace to recommit to social distancing measures and mask-wearing, pointing to scientific models that suggest the practices could save 50,000 lives over the coming months. He has insisted members of his administration model best behaviours for the country. Those messages found few champions in the former administration, as Trump openly flouted science-based guidance from his own administration. Face coverings were sparse at his reelection rallies and social distancing nearly nonexistent. In the weeks leading up to Biden’s inauguration, the U.S. set records in new cases and reported deaths almost by the day, as many states reimposed costly restrictions to slow the spread of the virus. Even so, Trump restricted media appearances by his top scientists and public health officials and continued to spread misinformation. Asked by CNN last week if the lack of candour from the Trump administration about the virus had cost lives, Dr. Anthony Fauci, the nation's top infectious disease expert, replied, “You know, it very likely did.” The Trump administration ended the practice of regular scientific briefings early on in the pandemic, after Trump expressed anger over the dire warnings of Centers for Disease Control and Prevention Dr. Nancy Messonnier in February about the threat from the virus. Trump later told journalist Bob Woodward that he had been “playing it down” to avoid creating panic about the virus. Aides said he also was trying to protect the economy to boost his reelection prospects. As the pandemic took hold in the U.S. last spring, Trump adopted the position of a “wartime president,” holding extended briefings at the White House, where he — not science — was the star. Trump pointed to the strong television ratings for his early appearances and timed the sessions to overtake the national evening news. From the briefing room, Trump shared his skepticism about face coverings, despite the widespread conclusions of scientists that wearing a mask helps prevent the spread of the virus. He wondered aloud if Americans could ingest toxic bleach to kill the virus like cleaning a surface. He encouraged governors to “reopen” their states, even as cases surged. Wednesday’s briefing will be conducted virtually, rather than in person at the White House, to allow for questions from health journalists and to maintain a set timing no matter the schedule in the West Wing. It will feature Jeff Zients, the Biden administration's co-ordinator for pandemic response; his deputy, Andy Slavitt; Fauci; Dr. Marcella Nunez-Smith, the chair of Biden's COVID-19 equality task force; and Dr. Rochelle Walensky, the director of the CDC. It comes as government scientists, led by Fauci, have been making regular media appearances to share their expertise in television and podcast interviews. Last week, Fauci called his current circumstances “liberating” and offered that “one of the new things in this administration is, if you don’t know the answer, don’t guess.” Hamer said that the Trump administration had created enough confusion and distrust around the coronavirus and the vaccine that the Biden administration has a long way to go to rebuild public trust, adding that some Americans may never come around. “It will take time. It’s hard to say exactly how much damage has been done,” he said. “I think there could be pockets within the country that may be more resistant to listening to evidence, because they may have set their minds on what they’ve heard from the past. But others still can be swayed and educated.” ___ Associated Press writer Alexandra Jaffe contributed to this report. Zeke Miller, The Associated Press
The film has been written, directed and edited by Tamhane and produced by Alfonso Cuaron.
Bailiffs from the National Eviction Team had moved in before 5am, according to HS2 Rebellion, but many protesters remain.
The "Digital Content - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The Prime Minister said he takes ‘full responsibility’ for the choices made by his Government.